For research use only. Not for therapeutic Use.
MDV 3100-d6 (Enzalutamide-d6) (Cat No.:C000705) is a deuterium-labeled derivative of enzalutamide, a medication used in the treatment of advanced prostate cancer. The deuterium substitution enhances molecular stability and aids in precise isotopic labeling for research purposes. Enzalutamide is an androgen receptor inhibitor, blocking the effects of androgens on cancer growth. Research involving MDV 3100-d6 likely focuses on pharmacokinetic studies, metabolism analysis, and drug interactions.
| Catalog Number | C000705 |
| CAS Number | 1443331-94-9 |
| Synonyms | 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide-d6; MDV3100-d6; |
| Molecular Formula | C₂₁H₁₀D₆F₄N₄O₂S |
| Purity | ≥95% |
| Target | Androgen Receptor |
| Solubility | Chloroform (Slightly), Methanol (Slightly) |
| Appearance | White to Off-White Solid |
| Storage | 4°C, Inert atmosphere |
